ClinicalTrials.govpublic full text
Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
chronic kidney disease, secondary hyperparathyroidism, chronic renal insufficiency, chronic renal failure, parathyroid diseases, renal insufficiency, kidney failure, chronic, hyperparathyroidism, secondary, vitamin d, hyperparathyroidism, renal insufficiency, chronic, kidney diseases
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 879739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.